tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Soumit Roy, 22 are a BUY (70.97%), 9 are a HOLD (29.03%).
Analyst Soumit Roy, currently employed at JONESTRADING, carries an average stock price target met ratio of 25.64% that have a potential upside of 36.13% achieved within 54 days.
Soumit Roy’s has documented 53 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on JANX, Janux Therapeutics at 03-Dec-2024.
Analyst best performing recommendations are on CGEM (CULLINAN ONCOLOGY LLC).
The best stock recommendation documented was for CGEM (CULLINAN ONCOLOGY LLC) at 4/16/2024. The price target of $26 was fulfilled within 13 days with a profit of $8.68 (50.12%) receiving and performance score of 38.55.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$23
$-2.59 (-10.12%)
$23
9 months 12 days ago
(10-May-2024)
6/9 (66.67%)
$-2.36 (-9.31%)
90
Sell
$26
$0.41 (1.60%)
$9
9 months 23 days ago
(30-Apr-2024)
3/10 (30%)
$0.73 (2.89%)
235
Hold
$22
9 months 23 days ago
(30-Apr-2024)
2/3 (66.67%)
$2.24 (11.34%)
67
Hold
$23
9 months 24 days ago
(29-Apr-2024)
4/6 (66.67%)
$8.58 (59.50%)
352
Hold
$16
$-9.59 (-37.48%)
9 months 24 days ago
(29-Apr-2024)
0/3 (0%)
$-9.28 (-36.71%)
Which stock is Soumit Roy is most bullish on?
What Year was the first public recommendation made by Soumit Roy?
